Form 8-K - Current report:
SEC Accession No. 0001069530-22-000051
Filing Date
2022-10-27
Accepted
2022-10-27 16:03:23
Documents
16
Period of Report
2022-10-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sava-20221013x8k.htm   iXBRL 8-K 95809
2 EX-10.1 sava-20221013xex10_1.htm EX-10.1 74951
3 EX-99.1 sava-20221013xex99_1.htm EX-99.1 20201
4 GRAPHIC sava-20221013xex10_1g001.jpg GRAPHIC 26443
5 GRAPHIC sava-20221013xex99_1g001.jpg GRAPHIC 26443
  Complete submission text file 0001069530-22-000051.txt   400907

Data Files

Seq Description Document Type Size
6 EX-101.SCH sava-20221013.xsd EX-101.SCH 2658
7 EX-101.LAB sava-20221013_lab.xml EX-101.LAB 15226
8 EX-101.PRE sava-20221013_pre.xml EX-101.PRE 10843
10 EXTRACTED XBRL INSTANCE DOCUMENT sava-20221013x8k_htm.xml XML 4875
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

IRS No.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29959 | Film No.: 221337296
SIC: 2834 Pharmaceutical Preparations